1. Homburg R. The management of infertility associated with PCOS. Reprod Biol Endocrinol. 2003;1:109. [DOI via Crossref] |
|
2. Shannon M, Wang Y. Polycystic ovary syndrome: a common but often unrecognized condition. J Midwifery Womens Health. 2012;57(3):221-30. [DOI via Crossref] |
|
3. Goudas VT, Dumesic DA. Polycystic ovary syndrome. Endocrinol Metab Clin North Am. 1997;26:893-912. [DOI via Crossref] |
|
4. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril. 2004;81(1):19-25. [DOI via Crossref] |
|
5. Azziz R. Diagnostic criteria for PCOS a reappraisal. Fertil Steril. 2000;83:1343-46. [DOI via Crossref] |
|
6. Atiomo WU, Pearson S, Shaw S, Dubbins P. Ultrasound criteria in the diagnosis of PCOS. Ultrasound Med Biol 2000;19:41-47. |
|
7. Eijkemans MJ, Imani B, Mulders AG, Habbema JD, Fauser BC. High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2) Hum Reprod. 2003;18:2357-2362. [DOI via Crossref] |
|
8. Thatcher SS, Jackson EM. Pregnancy outcome in infertile patients with PCOS who were treated with metformin. Fertil Steril. 2006;85:1002-9. [DOI via Crossref] |
|
9. Barberi RL. Metformin for the treatment of polycystic ovary syndrome. Obstet Gynecol. 2003;101(4):785-93. [DOI via Crossref] |
|
10. Panidis D, Tziomalos K, Chatzis P, Papadakis E, Delkos D, Tsourdi EA, et al. Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the PCOS. Eur J Endocrinol. 2013;168:145-52. [DOI via Crossref] |
|
11. Oh JY, Sung YA, Lee HJ. Clinical implications of menstrual cycle length in oligomenorrhoeic young woman. Clin Enocrinol. 2013;11:44-48. |
|
12. Panidis D, Tziomalos K, Papadakis E, Vosnakis C, Chatzis P. Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility. Endocrine. 2013;10:22-25. |
|
13. Roe AH, Dokras A. The Diagnosis of Polycystic Ovary Syndrome in Adolescents. Rev Obstet Gynecol. 2011; 4(2): 45-51. |
|
14. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. The consensus on infertility treatment related with PCOS. Human Reproduct. 2008;23:462-77. |
|
15. Kar S. Clomiphene citrate or latrozole as first line ovulation induction drug in infertile patients with PCOS. J Hum Reprod Sci. 2012;5:262-5. [DOI via Crossref] |
|
16. Vause TD, Cheung AP, Sierra S, Claman P, Graham J, Guillemin JA, et al. Ovulation induction in PCOS. J Obstet Gynaecol Can. 2010;32(5):495-502. |
|
17. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril. 2001;75:310-15. [DOI via Crossref] |
|
18. Poujade O, Gervaise A. Surgical management of infertility due to PCOS after failure of medical management. Eur J Obstet Gynaecol Reprod Biol. 2011;158;242-7. [DOI via Crossref] |
|
19. Palomba S, Falbo A, Battista L, Russo T, Venturella R, Tolino A, et al. Laproscopic ovarian diathermy vs clomiphene citrate plus metformin as second line strategy for infertile anovulatory patients with PCOS:a randomised controlled trial. Am J Obstet Gynaecol. 2010;202:577. [DOI via Crossref] |
|
20. Farquhar C, Brown J, Marjoribanks J. Laparoscopic drilling by diathermy or laser for ovulation induction in PCOS. Cochrane Database Syst Rev. 2007;3:.7-10. |
|